Laboratorio Reig Jofre, S.A. (LON:0RB1)

Market Cap	189.69M +10.5%
Revenue (ttm)	288.34M -1.0%
Net Income	3.71M -55.5%
EPS	0.05
Shares Out	n/a
PE Ratio	51.13
Forward PE	99.15
Dividend	0.03 (1.23%)
Ex-Dividend Date	May 15, 2025

Volume	2
Average Volume	617
Open	2.750
Previous Close	2.720
Day's Range	2.700 - 2.750
52-Week Range	2.550 - 3.380
Beta	1.00
RSI	46.78
Earnings Date	Feb 27, 2026

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmacy, food, and animal food. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements und...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1929
• Employees: 1,426
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RB1

Financial Performance

In 2024, Laboratorio Reig Jofre's revenue was 341.37 million, an increase of 7.36% compared to the previous year's 317.95 million. Earnings were 10.38 million, an increase of 10.36%.

Financial numbers in EUR